XBI

$127.10

Fund Essentials - as of Sep 30, 2025

Net Assets
$7.9B
Expense Ratio
0.35%
Dividend Yield (Current)
0.03%
Holdings
136
Inception Date
Jan 31, 2006
Fund Family
State Street Investment Management
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Quarterly
SEC 30-Day Yield
••••••••••

Performance

YTD+0.03%
1 Year+0.37%
3 Year+0.38%
5 Year-0.22%
10 Year+1.60%

Asset Allocation

Stocks: 99.88%
Cash: 0.07%
Other: 0.05%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
CRSP:SMCrispr Therapeutics Ag2.28%
ABBVAbbvie Inc.2.08%
MRNAModerna therapeutics2.04%
UTHRUTD THERAPEUT1.99%
EXELExelixis Inc - Common1.97%
Top 10 Concentration: 19.93%Report Date: Sep 30, 2025

Dividend Summary

View Details →
Dividend Yield (Current)
0.03%
Frequency
Quarterly
Latest Distribution
$0.03
Sep 22, 2025
12M Distributions
3 payments
Total: $0.04

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
+2.66%
YTD
+36.52%
1 Year
+36.52%
3 Year
+38.29%

Top 10 Holdings (19.9% of portfolio)

#TickerNameSectorWeight
1CRSP:SMCrispr Therapeutics AgHealth Care2.28%
2ABBVAbbvie Inc.Health Care2.08%
3MRNAModerna therapeuticsHealth Care2.04%
4UTHRUTD THERAPEUTHealth Care1.99%
5EXELExelixis Inc - CommonHealth Care1.97%
6BIIBBiogen Idec Inc.Health Care1.95%
7REGNRegeneron PharmaceuticalsUnknown1.94%
8AMGNAmgen Inc.Health Care1.93%
9MDGLMadrigal Pharmaceuticals IncHealth Care1.88%
10VRTXVertex Pharmaceuticals IncHealth Care1.87%